vs
Brainsway Ltd.（BWAY）与GLAUKOS Corp（GKOS）财务数据对比。点击上方公司名可切换其他公司
BrainsWay是一家跨国医疗器械企业，成立于2003年，在美国和耶路撒冷均设有办公机构。该公司主打开发搭载H线圈的深部经颅磁刺激医疗器械，为抑郁症、强迫症、烟瘾提供非侵入式治疗方案。
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收
BWAY
GKOS
| Q4 25 | — | $143.1M | ||
| Q3 25 | — | $133.5M | ||
| Q2 25 | — | $124.1M | ||
| Q1 25 | — | $106.7M | ||
| Q4 24 | — | $105.5M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | — | $95.7M | ||
| Q1 24 | — | $85.6M |
净利润BWAYGKOS
| Q4 25 | — | $-133.7M | ||
| Q3 25 | — | $-16.2M | ||
| Q2 25 | — | $-19.7M | ||
| Q1 25 | — | $-18.1M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-21.4M | ||
| Q2 24 | — | $-50.5M | ||
| Q1 24 | — | $-40.8M |
毛利率BWAYGKOS
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% | ||
| Q1 24 | — | 76.3% |
营业利润率BWAYGKOS
| Q4 25 | — | -97.7% | ||
| Q3 25 | — | -12.3% | ||
| Q2 25 | — | -18.3% | ||
| Q1 25 | — | -19.4% | ||
| Q4 24 | — | -27.2% | ||
| Q3 24 | — | -25.5% | ||
| Q2 24 | — | -31.3% | ||
| Q1 24 | — | -45.6% |
净利率BWAYGKOS
| Q4 25 | — | -93.4% | ||
| Q3 25 | — | -12.2% | ||
| Q2 25 | — | -15.8% | ||
| Q1 25 | — | -17.0% | ||
| Q4 24 | — | -31.8% | ||
| Q3 24 | — | -22.1% | ||
| Q2 24 | — | -52.8% | ||
| Q1 24 | — | -47.7% |
每股收益（稀释后）BWAYGKOS
| Q4 25 | — | $-2.34 | ||
| Q3 25 | — | $-0.28 | ||
| Q2 25 | — | $-0.34 | ||
| Q1 25 | — | $-0.32 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | — | $-0.39 | ||
| Q2 24 | — | $-1.00 | ||
| Q1 24 | — | $-0.82 |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
